PRGO Q4 2018 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B-6.9% YoY

Gross Profit

$443M37.1% margin

Operating Income

$108M9.0% margin

Net Income

$81M6.8% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$194M

Free Cash Flow

$149M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$5.3B

Stockholders' Equity

$5.7B

Cash & Equivalents

$551M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.3B	-6.9%
Gross Profit	$443M	$513M	-13.6%
Operating Income	$108M	$159M	-32.2%
Net Income	$81M	$73M	+11.2%

Revenue Segments

Consumer Self-Care Americas

$617M52%

Consumer Self-Care International

$356M30%

RX Pharmaceuticals

$222M19%

Geographic Segments

UNITED STATES

$801M67%

Europe

$324M27%

Other Geographical Areas

$70M6%

IRELAND

$5M0%